Member Info for potnak

The SP can fall back to 0.5 for all I care. This is one time where the SP is not reflecting the potential. If we are going to enter the Covid race with TYK21801, we will get some sort of notification by the end of the month, IMO. 1p will come and go. Then we'll have to wait it out as usual and wait on news from SRA737, Aurora and TYK2\1802. News on any of the 4 compounds will see us at least at 1.5p. All four? Place your bets but only one of them has to stick.

Yes, I remember putting a trade on at 8 then went of to work. Sold the shares whilst still on the tram. Made 2k before I got to work. That was a Mr o rampathon.

Anyone mentioned AWOO? Made his fortune on 88e. Paid his mortgage off at 20 years old then came here to teach how to be the flamboyant trader on AIM.

Might have been me. Still nothing confirmed by the company though. For Aurora, I suspect if it is for Covid, they won't be able to tell us anyway. TYK2 is the big one. If the company comes out and say were in the race then the brakes are off.

Depends it it works. Like Thoth said last week. A sniff of a percent of revenue would make a lot us multi millionaires just with divis. Lets hope it works, eh? for everyone who is going to catch this disease.

May not be Tim but these tweets will be sanctioned by our advisers so they are legitimised that way.

I have been is SAR for that long that I am able to not look at this board and up until recently I could go all week without looking. I've seen all the all the research that some of the more bio experienced guys have posted. My holding here, over the years has fluctuated between 1 and 3 million shares and I have never doubted why initially I bought in. I have to admit that I was really sceptical about SDC1801 and Covid. I thought we should concentrate on licensing the molecule properly and not jump on this band wagon but in the last week or so, I have completely changed my mind. I spent a chunk of the weekend reading old SAR updates and research links and when you read them with hindsight. You can really see where SDC1801 fits into the equation. I still think we are on the back foot because ours is preclinical and we just don't have the resource to go out and push it. Hopefully, as I suspect, it good enough to sell itself and we are already talking to people. It's all very exciting.

I'll think we'll see 3p on the hint of SAR entering the Covid race.

Yes, and the higher the SP creeps up the better the base line is for a multibagger. Still think we'll hear something Covid related before the end of the month.

Still is cheap, Celtic. ??

I'd put a short on if I we're you, Dru.

Tim has always said he would take the option to raise if the market gave him the option to raise. The window of opportunity for Covid is small. remdesivir, despite some setbacks looks to be progressing as do vaccination developments. These are making the window of opportunity smaller. I've no doubt the TYK2 could help but the fast track option might be taken away if other drugs work now. Don't get me wrong. SAR could be on the verge if something massive but it all down to timing and largely out of our control.

Yes, Happy, I agree. I'm hopeful we won't need to place though. If our TYK2 is a fit for Covid. Just 1 mil upfront pending more tests will see us right. I still think we'll get something Covid related next or at least by the end of the month. If we do raise then it means Covid is off the table IMO.

IMO SAR won't place for Covid we can't do it on our own. We need big pharma with big money. A relatively small upfront would see us secure for a year or so. I wouldn't rule out a placing for ongoing costs if we continue to rise next week.

IMO - we'll get an RNS next week. Might not be the big one we want but something Covid related. I honestly think we we're already in talks for our TYK2 autoimmune compound and Covid has thrown an expensive spanner into the works. In theory, could someone take 1801 autoimmune but Covid 19 be exempt from that deal?, effectively splitting 1801? or is that too messy? I'm asking because, That's where I think we are.

I'd never put a stop on with the AIM market. I used to trade AIM stocks, had level 2 and you place buy orders in below the bid and watch the MM's take it down to fill it. It's got too volatile now. The twitter herd and rampers work together to pump and dump stock. Its just not worth it. Better to work on only investing what you can forward to lose and researching.

I honestly don't care about the Intra day. It can fall back to 0.5 for all I care. The SP has nothing to do with the potential here. I'm half expecting a share suspension prior to a deal announced. Traders a scratching around for shares and are probably making a bit of profit but the majority of shares are going to be held tight until this gets past 2p 3p maybe 5p. Then we might see some big sells.

1 mil shares @28p would be life changing to me. :-). I need in the region of £130k to be completely debt free. That would change my life. I've got 2.7 million shares at an average of 0.72 so a few options to top skim if it happens.

I've got enough shares to top skim on the way to 28p and still have a life changing amount of profit :-)

Betterbeware - Risk - it's as simple as that. The SRA733 compound looks to be good but Sierra have had to narrow down the targets. It could still fail PIII. Both our TYK2 compounds (SDC1801 and SDC1802) are preclinical. Huge odds of not getting to market. and Aurora was effectively shelved. Covid 19 has changed all that. If someone were to buyout SAR now based on Covid 19. They'd save 100's of millions, just in trial costs, if not billions. This is SAR's time. We'll never get anther opportunity like this.